Acelity said today it used proceeds from the sale of its LifeCell regenerative medicine to repay debt owed by the company and its subsidiaries Kinetic Concepts and KCI USA. The San Antonio, Texas-based company said it repaid in full the existing credit facilities of its Kinetic Concepts and KCI USA subsidiaries and redeemed all outstanding […]
Acelity
Allergan closes $3B Acelity LifeCell buy
Acelity said today that it closed the sale of its regenerative medicine unit, LifeCell, to Allergan (NYSE:AGN) for $2.9 billion in cash. The deal brings LifeCell’s regenerative medicine and reconstructive portfolio to Allergan, joining a portfolio of medical aesthetics, breast implant and tissue expander product lines. Dublin-based Allergan said it expects to bring in $450 million in revenue this year, growing […]
How Acelity plans to disrupt fee-for-service to build a value-based business
Value-based care is disrupting the old fee-for-service models in the U.S. healthcare industry, and medical device makers must adapt or perish. Here’s how wound care company Acelity is responding. The rise of value-based care in the U.S. is causing a major shift in the medical device industry. Health provider customers want to know how medical […]
Allergan picks up Acelity’s LifeCell biz for $2.9B
Acelity said today that it inked a definitive agreement with Allergan (NYSE:AGN) to sell its LifeCell business for $2.9 billion in cash. The deal will put LifeCell’s regenerative medicine and reconstructive portfolio under Allergan’s roof, joining its medical aesthetics, breast implant and tissue expander product lines. Dublin-based Allergan said it expects will generate approximately $450 million in […]
Acelity spikes $1B IPO
Wound care and regenerative medicine company Acelity yesterday spiked an initial public offering that could have fetched as much as $1 billion. Acelity, formerly Kinetic Concepts Inc., was acquired for $6.1 billion by Apax Partners and a pair of Canadian pension funds in a leveraged buyout in November 2011. The company, which makes wound care products, later […]
Tela Bio, Acelity’s LifeCell settle patent spat
Tela Bio and Acelity subsidiary LifeCell settled their patent infringement beef last month for terms that were not disclosed. Malvern, Pa.-based Tela Bio said the settlement puts to bed all state and federal court cases between the companies and allows it to keep making its OviTex line of reinforced scaffolds for abdominal surgery. “We are very pleased that we were able […]
Progenerative Medical licenses KCI’s tissue regeneration tech
UPDATED Sept. 19, 2016, with comment from Acelity. Progenerative Medical said this week that it inked an exclusive licensing agreement with Acelity subsidiary Kinetic Concepts Inc. for a negative-pressure technology portfolio it aims to develop for spine and general orthopedic procedures. The announcement is a long time coming for CEO James Poser, who worked at KCI […]
Acelity CFO Casey departs on the eve of $1.75B debt offering, $450m refi
UPDATED Sept. 13, 2016, with details on Casey’s move to Lending Club. Acelity CFO Tom Casey is stepping down effective Sept. 16 for the chief finance spot at Lending Club, as Acelity prepares for a $1.75 billion debt offering and a $675 refinancing, the wound care giant said today. Casey is slated to be replaced on an interim […]
Acelity to float $400m in senior notes offering, reports slimmed losses for Q4, FY2015
Acelity said today that through its subsidiaries Kinetic Concepts and KCI USA, the company will float $400 million in 1st lien senior unsecured notes through a private offering, and reported its Q4 and fiscal year 2015 earnings, with losses shrinking for both. The San Antonio, Texas-based company intends to use the funds to repay outstanding debt […]
Acelity acquires Snap wound treatment from Spiracur
Acelity, looking to accelerate its plans for a disposable negative-pressure wound therapy, said today that it acquired the Snap portable NPWT device from Spiracur for an undisclosed amount. San Antonio, Texas-based Acelity, which is preparing for an initial public offering that could fetch up to $1 billion, said the Snap system is designed to treat hard-to-heal wounds […]
Acelity says IPO could fetch up to $1B
Wound care and regenerative medicine company Acelity yesterday said it expects to raise as much as $1 billion in its forthcoming initial public offering as it looks for a way to pay down its debt. Acelity, formerly Kinetic Concepts Inc., was acquired for $6.1 billion by Apax Partners and a pair of Canadian pension funds in a […]